MALLINCKRODT BAKER, INC. -- BARIUM NITRATE -- 6810-00-174-9658
===================== Product Identification ===================== Product ID:BARIUM NITRATE MSDS Date:11/16/1999 FSC:6810 NIIN:00-174-9658 === Responsible Party === Company Name:MALLINCKRODT BAKER, INC. Address:222 RED SCHOOL LANE City:PHILLIPSBURG State:NJ ZIP:08865-2219 Country:US Info Phone Num:908-859-2151/ 800-582-2537 Emergency Phone Num:800-424-9300 Resp. Party Other MSDS Num.:B0432 Chemtrec Ind/Phone:(800)424-9300 CAGE:70829 === Contractor Identification === Company Name:COLUMBUS CHEMICAL INDUSTRIES INC Address:N 4335 TEMKIN RD Box:8 City:COLUMBUS State:WI ZIP:53925-0008 Country:US Phone:920-623-2140 CAGE:5Y144 Company Name:MALLINCKRODT BAKER, INC. Address:222 RED SCHOOL LANE Box:City:PHILLIPSBURG State:NJ ZIP:08865 Country:US Phone:800-582-2537 CAGE:70829 Company Name:PHOENIX INDUSTRIES INC Address:1519 CHAMBERLAYNE PARKWAY Box:City:RICHMOND State:VA ZIP:23222 Country:US Phone:804-264-5183/FAX: 264-5535 Contract Num:SP0450-01-M-D335 CAGE:0YED2 ============= Composition/Information on Ingredients ============= Ingred Name:BARIUM NITRATE CAS:10022-31-8 RTECS #:CQ9625000 Minumum % Wt:99. Maxumum % Wt:100. OSHA PEL:0.5 MG/M3 (BA) ACGIH TLV:0.5 MG/M3 (BA); 8990 ===================== Hazards Identification ===================== LD50 LC50 Mixture:ORAL RAT LD50: 355 MG/KG. Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO Health Hazards Acute and Chronic:INHALATION CAUSES IRRITATION TO RESPIRATORY TRACT. INGESTION: MAY CAUSE TIGHTNESS OF MUSCLES OF FACE AND NECK . MAY CAUSE KIDNEY DAMAGE. SKIN/EYE CONTACT CAUSES IRRITATION. REPEATED CONTACT WITH LIQU ID MAY CAUSE DRYNESS, CRACKING, SKIN IRRITATION. CAUSES EYE IRRITATION. AFFECTS THE CENTRAL NERVOUS SYSTEM. CHRONIC EFFECTS MAY BE SIMILAR TO THOSE FROM METHANOL EXPOSURE BECAUSE METHYL ACETATE CAN BE HYDROLYZED YIELDING METHANOL AND ACETIC ACID. OPTIC NERVE DAMAGE IS THE PREDOMINANT HAZARD. Explanation of Carcinogenicity:THIS COMPOUND CONTAINS NO INGREDIENTS AT CONCENTRATIONS OF 0.1% OR GREATER THAT ARE CARCINOGENS OR SUSPECT CARCINOGENS. Effects of Overexposure:COUGHING, SHORTNESS OF BREATH, TIGHTNESS OF MUSCLES OF FACE AND NECK, VOMITING, DIARRHEA, ABDOMINAL PAIN, MUSCULAR TREMORS, ANXIETY, WEAKNESS, LABORED BREATHING, CARDIAC IRREGULARITY, CONVULSIONS, DEA TH FROM CARDIAC AND RESPIRATORY FAILURE, SKIN IRRITATION, ITCHING, PAIN, EYE IRRITATION, REDNESS, PAIN. MAY CAUSE KIDNEY DAMAGE. Medical Cond Aggravated by Exposure:PERSONS WITH PRE-EXISTING SKIN AND NERVOUS SYSTEM DISORDERS OR IMPAIRED RESPIRATORY OR KIDNEY FUNCTION MAY BE MORE SUSCEPTIBLE TO THE EFFECTS OF THIS SUBSTANCE. ======================= First Aid Measures ======================= First Aid:EYES: IMMEDIATELY FLUSH WITH WATER FOR AT LEAST 15 MINUTES, LIFTING UPPER AND LOWER EYELIDS OCCASIONALLY. GET MEDICAL ATTENTION. SKIN: FLUSH WITH WATER FOR AT LEAST 15 MINUTES. REMOVE CLOTHING AND SHO ES. GET MEDICAL ATTENTION. INHALATION: REMOVE TO FRESH AIR. IF NOT BREATHING, GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN. GET MEDICAL HELP. INGESTION: GET MEDICAL ATTENTION IM MEDIATELY. INDUCE VOMITING AS DIRECTED BY MEDICAL PERSONNEL. NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON. SEE NEUTRALIZING AGENT. ===================== Fire Fighting Measures ===================== Flash Point:NONE Lower Limits:NOT GIVEN Upper Limits:NOT GIVEN Extinguishing Media:FOAM, DRY CHEMICAL, CARBON DIOXIDE, FLOODING AMOUNTS OF WATER IN EARLY STAGES OF FIRE. DO NOT USE WATER ON MOLTEN MATERIAL. Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING AND NIOSH-APPROVED SELF-CONTAINED BREATHING APPARATUS WITH FULL FACEPIECE OPERATED IN THE PRESSURE DEMAND OR OTHER POSITIVE PRESSURE MODE. Unusual Fire/Explosion Hazard:DO NOT RELEASE RUNOFF FROM FIRE CONTROL METHODS TO SEWERS OR WATERWAYS. STRONG OXIDIZER AND ITS HEAT OF REACTION WITH REDUCING AGENTS/COMBUSTIBLES MAY IGNITE. CONTACT WITH OXIDIZABLE SUBSTANCES MAY CA USE EXTREMELY VIOLENT COMBUSTION. EMITS NITROGEN OXIDES WHEN HEATED TO DECOMPOSITION. ================== Accidental Release Measures ================== Spill Release Procedures:VENTILATE AREA OF SPILL. KEEP UNNECESSARY AND UNPROTECTED PEOPLE AWAY FROM AREA OF SPILL. WEAR APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT. PICK UP AND PLACE IN A SUITABLE CONTAINER FOR RECLAMATION OR DISPOSAL, USING A METHOD THAT DOES NOT GENERATE DUST. Neutralizing Agent:AFTER VOMITING, A MIXTURE OF 1 TABLESPOON OF SODIUM OR MAGNESIUM SULFATE(EPSOM SALTS) DISSOLVED IN 8 OZ OF WATER ====================== Handling and Storage ====================== Handling and Storage Precautions:KEEP IN TIGHTLY CLOSED CONTAINER, STORED IN A COOL, DRY, VENTILATED AREA. PROTECT AGAINST PHYSICAL DAMAGE. ISOLATE FROM INCOMPATIBLES. Other Precautions:SEPARATE FROM COMBUSTIBLES, ORGANIC OR OTHER READILY OXIDIZABLE MATERIALS. AVOID STORAGE ON WOODEN FLOORS. CONTAINER OF THIS MATERIAL MAY BE HAZARDOUS WHEN EMPTY SINCE THEY RETAIN PRODUCT RESIDUES; OB SERVE ALL WARNINGS AND PRECAUTIONS LISTED FOR THE PRODUCT. ============= Exposure Controls/Personal Protection ============= Respiratory Protection:IF THE EXPOSURE LIMIT IS EXCEEDED, A FULL FACEPIECE RESPIRATOR WITH DUST/MIST FILTER MAY BE WORN UP TO 50 TIMES THE EXPOSURE LIMIT OR MAXIMUM USE CONCENTRATION SPECIFIED BY THE APPROPRIATE REGULATORY AGENCY OR REPSIRATOR SUPPLIER. Ventilation:A SYSTEM OF LOCAL/GENERAL EXHAUST IS RECOMMENDED TO KEEP EMPLOYEE EXPOSURES BELOW EXPOSURE LIMITS. Protective Gloves:IMPERVIOUS Eye Protection:CHEMICAL SAFETY GOGGLES Other Protective Equipment:WEAR IMPERVIOUS PROTECTIVE CLOTHING, INCLUDING BOOTS, GLOVES, LAB COAT, APRON OR COVERALLS, AS NECESSARY TO PREVENT SKIN CONTACT. AN EMERGENCY EYEWASH AND QUICK DRENCH SHOWER SHOULD BE AVAILABLE. Work Hygienic Practices:WASH HANDS THOROUGHLY WITH SOAP AND WATER BEFORE EATING, DRINKING, SMOKING OR USING TOILET FACILITIES. Supplemental Safety and Health NOTE TO PHYSICIAN: MONITOR PATIENTS WITH SIGNIFICANT INGESTION FOR RESPIRATORY, CARDIOVASCULAR, AND BLOOD PRESSURE STATUS. WATCH FOR CARDIAC ARRHYTHMIAS, RESPIRATORY FAILURE DUE TO FLACCID PARALYSIS O R RESPIRATORY MUSCLES, PULMONARY EDEMA,VOCAL CORD PARALYSIS, SEVERE HYPERTENSION & LATE EFFECT KIDNEY FAILURE. ================== Physical/Chemical Properties ================== HCC:D1 Boiling Pt:B.P. Text:DECOMPOSES Melt/Freeze Pt:=592.C, ######F Decomp Temp:Decomp Text:NOT GIVEN Vapor Pres:NO INFORMATION GIVEN Vapor Density:NO INFORMA Evaporation Rate & Reference:NOT GIVEN Solubility in Water:8.7 GRAMS/100G Appearance and Odor:WHITE CRYSTALS, NO ODOR. ================= Stability and Reactivity Data ================= Stability Indicator/Materials to Avoid:YES MAGNESIUM PLUS BARIUM OXIDE PLUS ZINC, ALUMINUM AND MAGNESIUM ALLOYS, COMBUSTIBLES, (PAPER, OIL, WOOD), ACIDS, OXIDIZERS. Stability Condition to Avoid:NONE SPECIFIED BY MANUFACTURER. Hazardous Decomposition Products:OXIDES OF NITROGEN AND TOXIC METAL FUMES =================== Toxicological Information =================== Toxicological Information:FOR BARIUM NITRATE: ORAL RAT LD50: 355 MG/KG. IRRITATION DATA: SKIN RABBIT 500 MG/24H MILD. EYE RABBIT 100 MG/24H SEVERE. ===================== Ecological Information ===================== Ecological:ENVIRONMENTAL FATE: THIS MATERIAL MAY BIOACCUMULATE TO SOME EXTENT. ENVIRONMENTAL TOXICITY: NO INFORMATION FOUND. ==================== Disposal Considerations ==================== Waste Disposal Methods:PROCESSING, USE OR CONTAMINATION OF THIS PRODUCT MAY CHANGE THE WASTE MANAGEMENT OPTIONS. STATE AND LOCAL DISPOSAL REGULATIONS MAY DIFFER FROM FEDERAL DISPOSAL REGULATIONS. DISPOSE OF CONTAINER AND UN USED CONTENTS IN ACCORDANCE WITH FEDERAL, STATE AND LOCAL REQUIREMENTS. =================== MSDS Transport Information =================== Transport Information:DOT & IMO: PROPER SHIPPING NAME: BARIUM NITRATE, HAZARD CLASS: 5.1, 6.1; UN/NA: UN1446; PACKING GROUP II. ===================== Regulatory Information ===================== SARA Title III Information:SARA 313: BARIUM NITRATE (10022-31-8), CHEMICAL CATEGORY: BARIUM COMPOUND. SARA 311/312: ACUTE- YES. CHRONIC- YES. FIRE- NO. PRESSURE- NO. REACTIVITY- NO. Federal Regulatory Information:CERCLA, RCRA, & TSCA: NO. ======================= Other Information ======================= Disclaimer (provided with this information by the compiling agencies): This information is formulated for use by elements of the Department of Defense. The United States of America in no manner whatsoever, expressly or implied, warrants this information to be accurate and disclaims all liability for its use. Any person utilizing this document should seek competent professional advice to verify and assume responsibility for the suitability of this information to their particular situation.